When should we use IL-6 antagonists (Tociluzimab) in #COVID19 ?
#BreatheEasy @ATSCritCare interviewed @msh_manu about his @JAMA_current article
Podcast link: https://t.co/HKxN21tMgV
They discuss #mortality, #LOS #infection risk & #steroid therapy https://t.co/K7GYQXWWzL